ApconiX at EUROTOX 2018

Dr Michael Morton, Professor Ruth Roberts, Dr Richard Knight and Dr Paul Duffy will be attending EUROTOX this September in Brussels. The theme for 2018 is “Toxicology Out of the Box” and reflects the federation’s willingness and enthusiasm to offer an innovative, forward-looking and imaginative scientific programme.  ‘”The theme for EUROTOX aligns perfectly with our plans to future proof drug discovery here at ApconiX”, commented Ruth Roberts, past president of EUROTOX.

Ruth will be giving a keynote lecture on Wednesday September 5th at 8:30 in the GOLD Hall entitled “Drug Discovery: If you want to see different results do things differently.”  Chair and Director in Drug Discovery at the University of Birmingham, Ruth will present lessons learned from over 20 years’ experience in pharmaceutical industry focusing on attrition, prediction and the challenges posed by nonclinical to clinical accordance.

Ruth will also be presenting “Repurposing of new medicines: opportunities and challenges” on Monday 3rd of September at 16:30 in the SILVER Hall in Session 12.

EUROTOX is being held in Brussels this year and runs the 2nd to 5th of September.  For more information see the EUROTOX website.  See the full programme here.

By |2018-08-15T09:24:31+00:00August 15th, 2018|Toxicology, Events|Comments Off on ApconiX at EUROTOX 2018

About the Author:

Professor Ruth A Roberts, PhD, ATS, FBTS, ERT, FRSB, FRCPath Director and Cofounder, ApconiX, UK and Chair and Director of Drug Discovery, University of Birmingham, UK Ruth is chair of drug discovery at Birmingham University, UK and Cofounder of ApconiX, an integrated toxicology and ion channel company that brings together a team of world-renowned nonclinical safety experts with over 400 years of drug discovery and development experience. Previously, Ruth was Global Head of Regulatory Safety at AstraZeneca and Director of Toxicology for Aventis. Ruth is an established science professional bringing rigorous expert thinking to toxicology, drug discovery and drug development. With >140 publications in peer reviewed journals, she is focused on reducing attrition attributable to safety and toxicity. A former president of the British Toxicology Society, former president of EUROTOX, former secretary to SOT and president elect of the Academy of Toxicological Sciences, Ruth was the recipient of the SOT Achievement award in 2002, the EUROTOX Bo Holmstedt Award in 2009 and the SOT Founders award in 2018 for outstanding leadership in toxicology.